The FDA and CDC warned Thursday of a small increased risk of developing Guillain-Barré syndrome in older adults after immunization with respiratory syncytial virus vaccines from GSK and Pfizer.
Tag Archive for: Guillain-Barre syndrome
The FDA has approved Pfizer’s respiratory syncytial virus vaccine, henceforth to carry the brand name Abrysvo, to prevent lower respiratory tract disease in older adults aged 60 years and above, the company announced Wednesday.
South Africa’s health regulator reported on Thursday a causal link between the death of an individual and Johnson & Johnson’s (J&J) (JNJ.N) COVID-19 vaccine, the first time such a direct link has been made in the country.
